Genetic associations with a fever after measles-containing vaccines

Children have elevated fever risk 1 to 2 weeks after the first dose of a measles-containing vaccine (MCV), which is likely affected by genetic, immunologic, and clinical factors. Fever after MCV is associated with febrile seizures, though may also be associated with higher measles antibody titers. T...

Full description

Bibliographic Details
Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Weiqi Wang, Alison E. Fohner, Amy Wiesner, Vida Shokoohi, John Coller, Karin Bok, Hayley A. Gans
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-06-01
Subjects:	mmr mmrv vaccine genetic factors fever antibody titers
Online Access:	http://dx.doi.org/10.1080/21645515.2020.1849520

Similar Items

Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
by: Ousseny Zerbo, et al.
Published: (2020-04-01)

Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
by: Ousseny Zerbo, et al.
Published: (2020-12-01)

Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany — A nationwide multi-center cross-sectional study
by: Wiebke Graf, et al.
Published: (2024-05-01)

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
by: The MMR-162 Study Group
Published: (2018-12-01)

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
by: Carla Vizzotti, et al.
Published: (2023-03-01)

Differences in timeliness, completeness and drop-out rates of MMRV and DTP containing vaccines among Ultra-Orthodox Jews and others in a deprived Northern Israel city: an ecological study
by: Avraham Jacobson, et al.
Published: (2025-05-01)

Knowledge, willingness, and hesitancy toward recommended vaccinations among pregnant and post-partum women: A cross-sectional survey in Italy
by: Grazia Miraglia del Giudice, et al.
Published: (2025-12-01)

Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context
by: Giacomo Casabona, et al.
Published: (2023-12-01)

Measles - a disease that should be a thing of the past, but returns
by: Katarzyna Głowacka, et al.
Published: (2019-04-01)

Serological status of measles, mumps, and rubella antibodies in HIV-positive women of childbearing age at a referral hospital in Iran
by: Sara Ghaderkhani, et al.
Published: (2025-04-01)

Impact of Measles Vaccination on the Acquisition and Frequency of Measles Infection in Province of Sindh
by: Ammarah Jamal, et al.
Published: (2017-12-01)

Measurement of Serum Antibody Titer against Measles in a group of Adults Receiving Measles-Rubella Mass Vaccination
by: Alireza Emami Naeini, et al.
Published: (2011-03-01)

Revisiting The Value of Anti-streptolysin O Titer in Children with Rheumatic Fever
by: Mohamed S. Eid, et al.
Published: (2022-01-01)

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink
by: Kayla E. Hanson, et al.
Published: (2023-04-01)

Association Between Subnational Vaccine Coverage, Migration, and Incident Cases of Measles, Mumps, and Rubella in Iraq, 2001–2016
by: Haley Comfort, et al.
Published: (2022-01-01)

Hubungan vaksin Measles, Mumps, Rubella (MMR) dengan Kejadian Autisme
by: Elsye Souvriyanti, et al.
Published: (2016-12-01)

Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles
by: Tom Woudenberg, et al.
Published: (2019-10-01)

The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies
by: Azzari C, et al.
Published: (2020-06-01)

A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults
by: Hiraku Sasaki, et al.
Published: (2019-09-01)

Measles Encephalomyelitis: Vaccine Failure Related
by: J Gordon Millichap
Published: (1999-07-01)

The 2019 measles epidemic in Bosnia and Herzegovina: What is wrong with the mandatory vaccination program?
by: Jurica Arapović, et al.
Published: (2019-08-01)

Knowledge, attitudes and opinions towards measles and the MMR vaccine across two NSW cohorts
by: Daniel Brieger, et al.
Published: (2017-12-01)

The Case for Assessing the Drivers of Measles Vaccine Uptake
by: Jessica Kaufman, et al.
Published: (2024-06-01)

Sociodemographic inequalities in the epidemiology and vaccine uptake within a large outbreak of measles in Birmingham, England, 2023 to 2024
by: Carol Chatt
Published: (2025-04-01)

A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
by: Pragya Gupta, et al.
Published: (2020-01-01)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
by: Huy Quang Quach, et al.
Published: (2022-11-01)

Immunological and Immunogenetic Aspects of Vaccination against Measles
by: V. I. Fomichev, et al.
Published: (2025-07-01)

DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing
by: Joel Yambert, et al.
Published: (2022-12-01)

A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine
by: Achdiat PA, et al.
Published: (2023-11-01)

Associations of adaptive immune cell subsets with measles, mumps, and Rubella−Specific immune response outcomes
by: Lin Wang, et al.
Published: (2023-12-01)

Risk and Spatial Spread of a Measles Outbreak in Texas
by: Martial Loth Ndeffo-Mbah, et al.
Published: (2026-06-01)

Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s
by: David A. Geier, et al.
Published: (2019-09-01)

Serological investigation of vaccine-induced antibodies for measles, rubella, and yellow fever viruses in children vertically exposed to Zika virus or with down syndrome
by: Débora Familiar-Macedo, et al.
Published: (2023-12-01)

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
by: Nitin Shah, et al.
Published: (2024-12-01)

Does Measles, Mumps, and Rubella (MMR) Vaccination Protect against COVID-19 Outcomes: A Nationwide Cohort Study
by: Epiphane Kolla, et al.
Published: (2022-11-01)

A qualitative interview study exploring barriers and facilitators to uptake of measles vaccination among healthcare workers at a London hospital
by: Nikki Heinze, et al.
Published: (2025-09-01)

Intralesional measles, mumps and rubella vaccine versus formic acid puncture in the treatment of common warts: A prospective randomised study
by: Myfanwy J D'Souza, et al.
Published: (2023-01-01)

Influenza and Measles-MMR: two case study of the trend and impact of vaccine-related Twitter posts in Spanish during 2015-2018
by: Lucia Prieto Santamaría, et al.
Published: (2022-01-01)

Timing of Measles, Mumps, and Rubella Vaccination: Secondary Outcomes from an Immunological Survey
by: Jana Zibolenová, et al.
Published: (2025-04-01)

A mathematical model for distributed waning of vaccine-derived immunity: Characterizing dynamical impact on measles elimination
by: Aniruddha Deka, et al.
Published: (2024-12-01)